- Country: USA
- Summary: NICHD Biological Testing Facility (BTF)
- UST Ref No: 124463502
- Deadline: 28 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75N94020D00003
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
THIS IS A NOTICE OF INTENT TO AWARD WITHOUT PROVIDING FOR FULL AND OPEN COMPETITION. THIS IS NOT A SOLICITATION OR A REQUEST FOR COMPETITIVE PROPOSALS.
The purpose of this announcement is for the Contraceptive Development Program (CDP), within the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, to issue a modification on a sole source basis, under the authority of 41 U.S.C. 253 (c)(1) as implemented by FAR6.302-1,Only one responsible source and no other supplies or services will satisfy agency requirements and FAR 6.301-1(a)(2)(ii) to extend the ordering period of the existing IDIQ contract with SRI International (SRI), entitled “NICHD Biological Testing Facility (BTF).”
The objective is to extend the ordering period to ensure continuation of mission critical research while the NICHD procurement team continues to pursue the re-competition of these services under a new full and open cost reimbursement contract.
The proposed twenty-seven (27) month extension of the ordering period is necessary to prevent a lapse in continuity of critical services essential to the NICHD BTF and Contraceptive Clinical Trials Network (CCTN). This will ensure uninterrupted support for the conduct, coordination, and regulatory compliance of ongoing preclinical Good Laboratory Practices (GLP) studies and Good Manufacturing Practices (GMP) of investigational products (IP), and clinical contraceptive studies, avoiding costly and mission-compromising delays that would arise from a transition to a new contractor at this stage. Specifically, this action is necessary to ensure SRI continues providing the preclinical and clinical services supporting ongoing CCTN Phase I-III contraceptive clinical trial activities under Good Clinical Practices guidelines. SRI will also continue providing ancillary services such as meeting coordination, GMP investigational product (IP) manufacture, rele... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNICHD Biological Testing Facility (BTF) - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for NICHD Biological Testing Facility (BTF). This tender is published on USARFP under UST Ref No: 124463502 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-28.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
